Back to search
Primary Mild and Moderate Hypertension
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Mild and Moderate Hypertension trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Mild and Moderate Hypertension trials you may qualify forCataract is the leading cause of reversible vision loss, while glaucoma remains the primary cause of irreversible blindness, often impairing contrast sensitivit…
The purpose of this study is to assess the safety and effectiveness of the Hydrus Microstent for lowering intraocular pressure (IOP) in pseudophakic patients wi…
To quantitatively analyze the total radioactivity in the excreta of healthy male subjects after oral administration of \[14C\] SPH3127, and determine the cumula…
A phase 3 clinical study to evaluate the safety and efficacy of Azilsartan in Chinese hypertension patients